NEW BRUNSWICK: Johnson & Johnson said Tuesday it plans to separate its orthopedics business into a standalone company named DePuy Synthes within the next 18 to 24 months, marking its second major spinoff in two years. The move comes as the health-care conglomerate raised its 2025 product revenue forecast to a range of $93.5…
SYDNEY: Australian-listed medical technology company Uscom Limited said on Tuesday it has agreed to sell its entire business and assets to Singapore-based investment fund AXO Medtech VCC, a move aimed at rescuing the loss-making firm. The sale, which is subject to shareholder approval at a general meeting scheduled for Nov. 11, will see Uscom divest…